Aims & Scope
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:
- Medicinal chemistry, prevention, diagnosis, and treatment of malignant diseases
- In silico studies of drug-target interaction in anti-cancer drug assessment
- Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
- New drugs related to a specific target or target class for anticancer drugs
- Drug repositioning in cancer
- Clinical cancer research
- Radiotherapy and systemic treatment of cancer
- Other related areas
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Abstracted/Indexed in
BIOBASE, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, British Library, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE/Excerpta Medica, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.

Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells,
2014 :14 (10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz
DOI: 10.2174/1871520614666140624110458
View Abstract
Rights and Permissions
I had a good experience with the cooperative staff of Bentham Science Publication. The procedures were performed in timely and the services were of best quality.
Dorsa Golestaneh
(Department of Pharmaceutics, Faculty of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran.)
Has contributed: Enhancement in Biological Activity of L-Asparginase by its Conjugation on Silica Nanoparticles.